The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

A••• B•••••••••

Pharmaceuticalsgroup grade Aoff every schedule since Mar 31, 2025sponsor not established · possible relationship
See every lender's markFind rescue capital
More
Special situations PE firms

Nothing material in the last 200 days. No dated change on record yet.

Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$24.9M
n/a on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
0
1 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Mar 31, 2025
latest Mar 31, 2025
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Mar 31, 2025, folded to one row per lender
LenderExposureCurrent markQoQ change
A••••• D••• S•••••••• B••no principal filed100¢new this quarter
M••••• F•••••••• I••••••••• C•••no principal filed100¢new this quarter
Every BDC piece · 2 positions across 2 lenderslargest principal first, with instrument and rate
BDCInstrumentPrincipalFair valueRate
A••••• D••• S•••••••• B••unstated lien unstatedNot disclosed$14.5M
100c
M••••• F•••••••• I••••••••• C•••unstated lien unstatedNot disclosed$10.4M
100c
Capital structure as the BDCs see it
latest quarter end Mar 31, 2025
No debt facility on the tape for this borrower; the BDC pieces are equity.
Equity pieces beside the debt: other ($24.9M fair value, 2 BDCs)
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Mar 31, 20252$0$0n/a0
What changed
Every change including routine ones
Identity
Group key
A••• B•••••••••derivedthe codename stem after legal suffixes and deal words
Spellings
1 across 2 BDCsderived
Industry
Pharmaceuticalsreportedas one filer wrote it